A defective flexible loop contributes to the processing and gating defects of the predominant cystic fibrosis‐causing mutation
暂无分享,去创建一个
H. Senderowitz | Jeng-Haur Chen | Samuel J. Bose | Xinying Chen | Siyu Zhu | Michael Zhenin | Weiyi Xu | Molly Pik‐Fan Wong | G. Leung
[1] Nikhil T. Awatade,et al. R560S: A class II CFTR mutation that is not rescued by current modulators. , 2019, Journal of Cystic Fibrosis.
[2] Nikhil T. Awatade,et al. Partial rescue of F508del‐cystic fibrosis transmembrane conductance regulator channel gating with modest improvement of protein processing, but not stability, by a dual‐acting small molecule , 2018, British journal of pharmacology.
[3] S. Rowe,et al. Toward inclusive therapy with CFTR modulators: Progress and challenges , 2017, Pediatric pulmonology.
[4] Jue Chen,et al. Conformational Changes of CFTR upon Phosphorylation and ATP Binding , 2017, Cell.
[5] D. Clarke,et al. Corrector VX‐809 promotes interactions between cytoplasmic loop one and the first nucleotide‐binding domain of CFTR , 2017, Biochemical pharmacology.
[6] V. Vauthier,et al. Targeted pharmacotherapies for defective ABC transporters , 2017, Biochemical pharmacology.
[7] R. Mahalakshmi,et al. Metamorphic Proteins: Emergence of Dual Protein Folds from One Primary Sequence. , 2017, Biochemistry.
[8] D. Gadsby,et al. Molecular Structure of the Human CFTR Ion Channel , 2017, Cell.
[9] D. Sheppard,et al. Altering intracellular pH reveals the kinetic basis of intraburst gating in the CFTR Cl− channel , 2017, The Journal of physiology.
[10] R. Ford,et al. Two Small Molecules Restore Stability to a Subpopulation of the Cystic Fibrosis Transmembrane Conductance Regulator with the Predominant Disease-causing Mutation* , 2017, The Journal of Biological Chemistry.
[11] Jue Chen,et al. Atomic Structure of the Cystic Fibrosis Transmembrane Conductance Regulator , 2016, Cell.
[12] I. Sabirzhanova,et al. Correctors Rescue CFTR Mutations in Nucleotide‐Binding Domain 1 (NBD1) by Modulating Proteostasis , 2016, Chembiochem : a European journal of chemical biology.
[13] R. Nussinov,et al. The Role of Protein Loops and Linkers in Conformational Dynamics and Allostery. , 2016, Chemical reviews.
[14] Hanoch Senderowitz,et al. REMD Simulations Reveal the Dynamic Profile and Mechanism of Action of Deleterious, Rescuing, and Stabilizing Perturbations to NBD1 from CFTR , 2015, J. Chem. Inf. Model..
[15] J. Riordan,et al. Restoration of NBD1 thermal stability is necessary and sufficient to correct ∆F508 CFTR folding and assembly. , 2015, Journal of Molecular Biology.
[16] A. Toye,et al. CFTR potentiators partially restore channel function to A561E‐CFTR, a cystic fibrosis mutant with a similar mechanism of dysfunction as F508del‐CFTR , 2014, British Journal of Pharmacology.
[17] M. Amaral,et al. Revertant mutants modify, but do not rescue, the gating defect of the cystic fibrosis mutant G551D‐CFTR , 2014, The Journal of physiology.
[18] Piotr Zielenkiewicz,et al. Discovery of novel potent ΔF508-CFTR correctors that target the nucleotide binding domain , 2013, EMBO molecular medicine.
[19] Sadis Matalon,et al. The silent codon change I507‐ATC→ATT contributes to the severity of the ΔF508 CFTR channel dysfunction , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[20] M. Amaral,et al. Rescuing mutant CFTR: a multi-task approach to a better outcome in treating cystic fibrosis. , 2013, Current pharmaceutical design.
[21] G. Lukács,et al. Mechanism-based corrector combination restores ΔF508-CFTR folding and function , 2013, Nature Chemical Biology.
[22] T. Hwang,et al. Vx-770 potentiates CFTR function by promoting decoupling between the gating cycle and ATP hydrolysis cycle , 2013, Proceedings of the National Academy of Sciences.
[23] Xuehong Liu,et al. Thermal instability of ΔF508 cystic fibrosis transmembrane conductance regulator (CFTR) channel function: protection by single suppressor mutations and inhibiting channel activity. , 2012, Biochemistry.
[24] Pradeep Kota,et al. Allosteric modulation balances thermodynamic stability and restores function of ΔF508 CFTR. , 2012, Journal of molecular biology.
[25] K. Du,et al. Correction of Both NBD1 Energetics and Domain Interface Is Required to Restore ΔF508 CFTR Folding and Function , 2012, Cell.
[26] Philip J. Thomas,et al. Requirements for Efficient Correction of ΔF508 CFTR Revealed by Analyses of Evolved Sequences , 2012, Cell.
[27] M. Welsh,et al. Human–mouse cystic fibrosis transmembrane conductance regulator (CFTR) chimeras identify regions that partially rescue CFTR-ΔF508 processing and alter its gating defect , 2011, Proceedings of the National Academy of Sciences.
[28] K. Kirk,et al. Thermally Unstable Gating of the Most Common Cystic Fibrosis Mutant Channel (ΔF508) , 2011, The Journal of Biological Chemistry.
[29] A. Mehta,et al. Contribution of Casein Kinase 2 and Spleen Tyrosine Kinase to CFTR Trafficking and Protein Kinase A-Induced Activity , 2011, Molecular and Cellular Biology.
[30] S. Richter,et al. The ΔF508 Mutation Causes CFTR Misprocessing and Cystic Fibrosis–Like Disease in Pigs , 2011, Science Translational Medicine.
[31] Philip J. Thomas,et al. The Primary Folding Defect and Rescue of ΔF508 CFTR Emerge during Translation of the Mutant Domain , 2010, PloS one.
[32] M. Welsh. Targeting the basic defect in cystic fibrosis. , 2010, New England Journal of Medicine.
[33] Efrat Ben-Zeev,et al. Small molecule correctors of F508del-CFTR discovered by structure-based virtual screening , 2010, J. Comput. Aided Mol. Des..
[34] Zhengrong Yang,et al. Thermal unfolding studies show the disease causing F508del mutation in CFTR thermodynamically destabilizes nucleotide‐binding domain 1 , 2010, Protein science : a publication of the Protein Society.
[35] Zhengrong Yang,et al. Integrated biophysical studies implicate partial unfolding of NBD1 of CFTR in the molecular pathogenesis of F508del cystic fibrosis , 2010, Protein science : a publication of the Protein Society.
[36] Pradeep Kota,et al. Regulatory insertion removal restores maturation, stability and function of DeltaF508 CFTR. , 2010, Journal of molecular biology.
[37] Jason C. Young,et al. Peripheral Protein Quality Control Removes Unfolded CFTR from the Plasma Membrane , 2010, Science.
[38] Kenneth L. Nesbitt,et al. Restoration of domain folding and interdomain assembly by second‐site suppressors of the ΔF508 mutation in CFTR , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[39] H. Senderowitz,et al. The Cystic Fibrosis-causing Mutation ΔF508 Affects Multiple Steps in Cystic Fibrosis Transmembrane Conductance Regulator Biogenesis* , 2010, The Journal of Biological Chemistry.
[40] D. Clarke,et al. The V510D Suppressor Mutation Stabilizes ΔF508-CFTR at the Cell Surface† , 2010, Biochemistry.
[41] John F Hunt,et al. Structures of a minimal human CFTR first nucleotide-binding domain as a monomer, head-to-tail homodimer, and pathogenic mutant. , 2010, Protein engineering, design & selection : PEDS.
[42] J. M. Sauder,et al. Structure and dynamics of NBD1 from CFTR characterized using crystallography and hydrogen/deuterium exchange mass spectrometry. , 2010, Journal of molecular biology.
[43] Julie D Forman-Kay,et al. NMR evidence for differential phosphorylation‐dependent interactions in WT and ΔF508 CFTR , 2010, The EMBO journal.
[44] D. Cyr,et al. Assembly and misassembly of cystic fibrosis transmembrane conductance regulator: folding defects caused by deletion of F508 occur before and after the calnexin-dependent association of membrane spanning domain (MSD) 1 and MSD2. , 2008, Molecular biology of the cell.
[45] Adrian W. R. Serohijos,et al. Phenylalanine-508 mediates a cytoplasmic–membrane domain contact in the CFTR 3D structure crucial to assembly and channel function , 2008, Proceedings of the National Academy of Sciences.
[46] Nikolay V. Dokholyan,et al. Diminished Self-Chaperoning Activity of the ΔF508 Mutant of CFTR Results in Protein Misfolding , 2008, PLoS Comput. Biol..
[47] M. Amaral,et al. Solubilizing mutations used to crystallize one CFTR domain attenuate the trafficking and channel defects caused by the major cystic fibrosis mutation. , 2008, Chemistry & biology.
[48] M. Welsh,et al. Processing and function of CFTR-ΔF508 are species-dependent , 2007, Proceedings of the National Academy of Sciences.
[49] C. Soares,et al. Revertant mutants G550E and 4RK rescue cystic fibrosis mutants in the first nucleotide-binding domain of CFTR by different mechanisms , 2006, Proceedings of the National Academy of Sciences.
[50] Kai Du,et al. Small-molecule correctors of defective DeltaF508-CFTR cellular processing identified by high-throughput screening. , 2005, The Journal of clinical investigation.
[51] J. M. Sauder,et al. Impact of the ΔF508 Mutation in First Nucleotide-binding Domain of Human Cystic Fibrosis Transmembrane Conductance Regulator on Domain Folding and Structure* , 2005, Journal of Biological Chemistry.
[52] J. M. Sauder,et al. Structure of nucleotide‐binding domain 1 of the cystic fibrosis transmembrane conductance regulator , 2004, The EMBO journal.
[53] L. Gansheroff,et al. Mutations in the Nucleotide Binding Domain 1 Signature Motif Region Rescue Processing and Functional Defects of Cystic Fibrosis Transmembrane Conductance Regulator ΔF508* , 2002, The Journal of Biological Chemistry.
[54] D. Sheppard,et al. Phloxine B Interacts with the Cystic Fibrosis Transmembrane Conductance Regulator at Multiple Sites to Modulate Channel Activity* 210 , 2002, The Journal of Biological Chemistry.
[55] Fei Wang,et al. Deletion of phenylalanine 508 causes attenuated phosphorylation‐dependent activation of CFTR chloride channels , 2000, The Journal of physiology.
[56] J. Riordan,et al. Removal of multiple arginine-framed trafficking signals overcomes misprocessing of delta F508 CFTR present in most patients with cystic fibrosis. , 1999, Molecular cell.
[57] K. Kirk,et al. Activation of ΔF508 CFTR in an epithelial monolayer. , 1998, American journal of physiology. Cell physiology.
[58] T. Hwang,et al. Genistein potentiates wild-type and delta F508-CFTR channel activity. , 1997, The American journal of physiology.
[59] P. Thomas,et al. Alteration of the Cystic Fibrosis Transmembrane Conductance Regulator Folding Pathway , 1996, The Journal of Biological Chemistry.
[60] M. Welsh,et al. The Two Nucleotide-binding Domains of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Have Distinct Functions in Controlling Channel Activity (*) , 1995, The Journal of Biological Chemistry.
[61] R. Frizzell,et al. ATP alters current fluctuations of cystic fibrosis transmembrane conductance regulator: evidence for a three-state activation mechanism , 1994, The Journal of general physiology.
[62] H. A. Berger,et al. Identification of revertants for the cystic fibrosis ΔF508 mutation using STE6-CFTR chimeras in yeast , 1993, Cell.
[63] Matthew P. Anderson,et al. Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive , 1992, Nature.
[64] P. Pedersen,et al. The cystic fibrosis transmembrane conductance regulator. Effects of the most common cystic fibrosis-causing mutation on the secondary structure and stability of a synthetic peptide. , 1992, The Journal of biological chemistry.
[65] F. Collins,et al. Chloride conductance expressed by delta F508 and other mutant CFTRs in Xenopus oocytes. , 1991, Science.
[66] Pascal Barbry,et al. Altered chloride ion channel kinetics associated with the ΔF508 cystic fibrosis mutation , 1991, Nature.
[67] J. Marshall,et al. Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis , 1990, Cell.
[68] L. Tsui,et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. , 1989, Science.
[69] Kaye Walizer. Defective , 2021, Encyclopedia of the UN Sustainable Development Goals.
[70] N. Dokholyan,et al. Correctors of F508 CFTR restore global conformational maturation without thermally stabilizing the mutant protein , 2014 .
[71] K. Kirk,et al. The CFTR ion channel: gating, regulation, and anion permeation. , 2013, Cold Spring Harbor perspectives in medicine.
[72] Paola Bisignano,et al. Molecular dynamics analysis of the wild type and dF508 mutant structures of the human CFTR-nucleotide binding domain 1. , 2010, Biochimie.
[73] M. Welsh,et al. Processing and function of CFTR-DeltaF508 are species-dependent. , 2007, Proceedings of the National Academy of Sciences of the United States of America.
[74] Chad A Brautigam,et al. Side chain and backbone contributions of Phe508 to CFTR folding , 2005, Nature Structural &Molecular Biology.
[75] Kai Du,et al. The ΔF508 cystic fibrosis mutation impairs domain-domain interactions and arrests post-translational folding of CFTR , 2005, Nature Structural &Molecular Biology.
[76] L. Gansheroff,et al. Mutations in the nucleotide binding domain 1 signature motif region rescue processing and functional defects of cystic fibrosis transmembrane conductance regulator delta f508. , 2002, The Journal of biological chemistry.
[77] M. Welsh,et al. Mutation of R555 in CFTR-delta F508 enhances function and partially corrects defective processing. , 1996, Receptors & channels.
[78] R. Crystal,et al. Altered chloride ion channel kinetics associated with the delta F508 cystic fibrosis mutation. , 1991, Nature.